BFA
PDSB icon

BlackRock Fund Advisors’s PDS Biotechnology PDSB Stock Holding History

BlackRock Fund Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.46M Buy
25,854
+3,570
+16% +$811K ﹤0.01% 2810
2016
Q3 		$4.64M Buy
22,284
+1,456
+7% +$288K ﹤0.01% 2878
2016
Q2 		$4.21M Buy
20,828
+10,072
+94% +$1.78M ﹤0.01% 2898
2016
Q1 		$1.97M Sell
10,756
-594
-5% -$106K ﹤0.01% 3084
2015
Q4 		$2.84M Buy
+11,350
New +$3.66M ﹤0.01% 3056

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Fund Advisors's PDSB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its PDS Biotechnology (PDSB) stake by 16% in Q4 2016, buying an estimated $811K and bringing the position to 25,854 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

BlackRock Fund Advisors first reported a position in PDSB in Q4 2015 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

  • BlackRock Fund Advisors held 25,854 shares of PDS Biotechnology worth $6.46M as of Q4 2016.
  • BlackRock Fund Advisors bought 3,570 PDS Biotechnology shares in Q4 2016, an estimated $811K.
  • PDS Biotechnology made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2810 holding.
  • BlackRock Fund Advisors first reported a position in PDS Biotechnology in Q4 2015 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.